NCT02229981View on ClinicalTrials.gov

Early Phase Evaluation of ABC294640 in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma or Kaposi Sarcoma

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 31, 2014

Primary Completion Date

June 30, 2019

Study Completion Date

December 31, 2019

Conditions
Diffuse Large B Cell LymphomaKaposi Sarcoma
Interventions
DRUG

ABC294640

Trial Locations (1)

70112

Louisiana State University Health Sciences Center, New Orleans

Sponsors
All Listed Sponsors
collaborator

Louisiana State University Health Sciences Center in New Orleans

OTHER

collaborator

Apogee Biotechnology Corporation

INDUSTRY

lead

RedHill Biopharma Limited

INDUSTRY